Triggers for intervention in patients with small renal masses undergoing active surveillance
Patients with small renal masses are often over diagnosed and [...]
The effect of age and gender on outcomes in kidney cancer
In this interview, Dr Rana McKay discusses the impact of [...]
Individualised axitinib dosing for patients with metastatic kidney cancer
In the following video interview with Practice Update, Dr Nancy [...]
Individualised treatment plans improve outcomes for kidney cancer
Over the past couple of years there have been several [...]
First CAR-T therapy for kidney cancer shows signs of efficacy
Chimeric antigen receptor T-cell (CAR-T) therapy is an immunotherapy specifically [...]
Long-term survival of kidney cancer patients with AGS-003 individualised immunotherapy
Argos Therapeutics, an immuno-oncology company focused on the development of [...]
Doctors could one day personalise treatment using your DNA
The following article is an interesting account of how sequencing [...]
